Correlating Brain Imaging with Peripheral Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to clearly elucidate the neural and molecular mechanisms of lithium's effectiveness in treating bipolar disorder due to ethical constraints on brain biopsy in humans, limiting understanding of its effects on brain tissue and molecular pathways.
Innovation Solution
Correlating changes in brain imaging, specifically using functional magnetic resonance imaging (fMRI) and structural data with peripheral gene expression to identify molecular signatures of lithium's action, employing independent component analysis (ICA) and fusion analysis to determine the effects on brain connectivity and gene expression pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If brain biopsy is performed to directly observe lithium's effects on brain tissue, then measurement precision of molecular mechanisms is improved, but ethical constraints and patient safety are compromised
Solution Approach 1:
The patent uses peripheral blood as an intermediary to indirectly measure brain molecular changes. Instead of directly sampling brain tissue through biopsy, the method correlates peripheral gene expression patterns with brain imaging data (PET/SPECT) to infer central nervous system molecular mechanisms. This mediator approach allows research on lithium's molecular effects without performing invasive brain biopsies on patients.
Solution Approach 2:
The patent replaces the mechanical/invasive approach of brain biopsy with non-invasive imaging techniques (PET, SPECT, fMRI) combined with peripheral blood gene expression analysis. This substitution uses functional and molecular imaging to visualize and measure brain changes without physical tissue removal, eliminating the harmful aspects of biopsy while preserving measurement capability.
2Loss of information
If multiple imaging modalities and gene expression data are integrated to comprehensively analyze lithium's effects, then understanding of molecular pathways is improved, but system complexity increases
Solution Approach 1:
The patent merges multiple data sources including PET imaging data, SPECT imaging data, fMRI functional connectivity data, and peripheral blood gene expression data into a unified analysis framework. By combining these diverse modalities, the study comprehensively captures structural, functional, and molecular aspects of lithium's effects on the brain, overcoming the limitations of any single method.
Solution Approach 2:
The patent develops a multi-functional integrated system that simultaneously performs structural imaging, functional imaging, and molecular analysis. This universal platform can assess multiple aspects of drug effects (anatomical changes, functional connectivity, gene expression) within a single research framework, making the complex system versatile for comprehensive neuropharmacological evaluation.
Data Source
AI summary
Systems and methods are provided for correlating functional magnetic resonance imaging (fMRI) with gene expression. Brains of first and second sets of patients are imaged at first and second times to provide first and second sets of fMRI images. Blood is drawn from each of the first and second sets of patients at the first and second times to provide first and second sets of gene expression transcripts. A therapeutic is administered to the first set of patients between the first and second times. A change in the connectivity of the brain for each patient is determined from the first and second sets of fMRI images. A set of changes in the peripheral lymphocyte gene expression that are correlated with changes in the connectivity of the brain are determined from the change in the connectivity of the brain for each patient and the collected imaging and gene expression data.